User login
- /content/dose-escalated-blinatumomab-plus-dexamethasone-induced-responses-relapsed/refractory-dlbcl
- /hematologynews/article/108248/aggressive-lymphomas/dose-escalated-blinatumomab-plus-dexamethasone
- /oncologypractice/article/108248/aggressive-lymphomas/dose-escalated-blinatumomab-plus-dexamethasone
- /hematologynews/nhlhub/article/108248/aggressive-lymphomas/dose-escalated-blinatumomab-plus
- /hematology-oncology/article/108248/aggressive-lymphomas/dose-escalated-blinatumomab-plus